Deccan Health Care Ltd. shows promising growth metrics, but it significantly trails its peers in profitability and efficiency. Companies like Cipla and Dr. Reddy's are standout performers, while Deccan remains a potential growth pick despite its high valuation. The sector displays a mix of strong performers and some financially weaker entities, highlighting opportunities and risks for investors.

• • Deccan Health Care Ltd. has strong revenue growth but low profitability metrics when compared to peers.
• • Cipla Ltd. and Dr. Reddy's Laboratories Ltd. lead in profitability and efficiency metrics.
• • Divi's Laboratories and Sun Pharmaceutical are among the more expensive stocks based on valuation metrics.